ID: ALA3884751

Max Phase: Preclinical

Molecular Formula: C25H38N2O6

Molecular Weight: 462.59

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)C(=O)CCCCc1ccc(OC)cc1)C(=O)NCC(=O)OC(C)(C)C

Standard InChI:  InChI=1S/C25H38N2O6/c1-7-17(2)22(24(31)26-16-21(29)33-25(3,4)5)27-23(30)20(28)11-9-8-10-18-12-14-19(32-6)15-13-18/h12-15,17,22H,7-11,16H2,1-6H3,(H,26,31)(H,27,30)/t17-,22-/m0/s1

Standard InChI Key:  YSZPVKQXUGJTRC-JTSKRJEESA-N

Associated Targets(Human)

Phospholipase A2 group V 238 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytosolic phospholipase A2 785 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Phospholipase A2 group 1B 51 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 462.59Molecular Weight (Monoisotopic): 462.2730AlogP: 2.97#Rotatable Bonds: 13
Polar Surface Area: 110.80Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.88CX Basic pKa: CX LogP: 3.97CX LogD: 3.97
Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.26Np Likeness Score: -0.25

References

1. Smyrniotou A, Kokotou MG, Mouchlis VD, Barbayianni E, Kokotos G, Dennis EA, Constantinou-Kokotou V..  (2017)  2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A2 inhibitors.,  25  (3): [PMID:28034646] [10.1016/j.bmc.2016.12.007]

Source